HIGH-DOSE DEXAMETHASONE AND ELTROMBOPAG IN CHRONIC IMMUNE THROMBOCYTOPENIA (ITP): A SINGLE INSTITUTION EXPERIENCE

被引:0
|
作者
Magro, D. [1 ]
Kropp, M. [1 ]
Levato, L. [1 ]
Piro, E. [1 ]
Molica, S. [1 ]
机构
[1] Azienda Osped Pugliese Ciaccio, Dipartimento Ematooncol, SOC Ematol, Catanzaro, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P033
引用
收藏
页码:63 / 63
页数:1
相关论文
共 50 条
  • [1] HIGH-DOSE DEXAMETHASONE AND ELTROMBOPAG IN CHRONIC IMMUNE THROMBOCYTOPENIA: A SINGLE INSTITUTION EXPERIENCE
    Magro, D.
    Levato, L.
    Piro, E.
    Kropp, M. G.
    Molica, S.
    HAEMATOLOGICA, 2016, 101 : 832 - 832
  • [2] The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
    Yassin, Mohamed A.
    Ghasoub, Rola
    Soliman, Ashraf
    Ismail, Omar
    Nashwan, Abdulqadir J.
    Alshurafa, Awni
    Ghori, Firdous
    Sideeg, Deena
    Hamad, Anas
    Hussein, Radwa
    Al-Okka, Randa
    Chandra, Prem
    Alasmar, Aya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [3] The Impact of Ethnicity on the Response to Eltrombopag in Patients with Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
    Yassin, Mohamed A.
    Alasmar, Aya
    Ghasoub, Rola
    Ismail, Omer
    Nashwan, Abdulqadir Jeprel
    Ghori, Firdous
    Sideeg, Deena
    Hussein, Radwa M.
    Al-Okka, Randa
    Chandra, Prem
    Hamad, Anas
    Soliman, Ashraf Tawfiq
    BLOOD, 2020, 136
  • [4] Eltrombopag and High-Dose Dexamethasone As First Line Treatment For ITP
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel Angel
    Gomez-de Leon, Andres
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz C.
    Ruiz-Arguelles, Guillermo J.
    Hernandez-Reyes, Jesus
    BLOOD, 2013, 122 (21)
  • [5] HIGH-DOSE DEXAMETHASONE IN IMMUNE THROMBOCYTOPENIA
    Fuentes, A.
    Subbiah, S.
    Rigby, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 594 - 595
  • [6] Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel A.
    Jaime-Perez, Jose C.
    Gomez-De Leon, Andres
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Tarin-Arzaga, Luz
    Hernandez-Reyes, Jesus
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2014, 123 (25) : 3906 - 3908
  • [7] ELTROMBOPAG FOR CHRONIC IMMUNE THROMBOCYTOPENIA: A SINGLE CENTER EXPERIENCE
    Arshanskaya, E.
    Semochkin, S.
    Ivanova, V.
    Ptushkin, V.
    HAEMATOLOGICA, 2016, 101 : 833 - 833
  • [8] Pulse high-dose dexamethasone in chronic childhood immune thrombocytopenic purpura (ITP).
    Kuhne, T
    Semple, JW
    Butchart, S
    Freedman, J
    Blanchette, VS
    BLOOD, 1995, 86 (10) : 3386 - 3386
  • [9] High-dose pulsed dexamethasone for immune thrombocytopenia
    Demiroglu, H
    Dundar, S
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06): : 425 - 426
  • [10] Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopenia
    Warner, M
    Wasi, P
    Couban, S
    Hayward, C
    Warkentin, T
    Kelton, JG
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 54 (04) : 267 - 270